As the first study of the specific issue, we’ve shown that there is no support of psychosocial environmental elements explaining the therefore called ‘paternal age effect’ [in schizophrenia risk], comment Mats team and Ek from the Karolinska Institute in Stockholm. Related StoriesTracking retinal changes may help doctors to regulate schizophrenia treatment in the futureUnderstanding how schizophrenia impacts workings of the brainPhase III trial outcomes show cariprazine effective in treating negative symptoms connected with schizophreniaThe researchers searched the Swedish Multi-Era Register and identified 31,188 kids adopted by Swedish families between 1955 and 1985. Using the National Patient Register, they found that 371 of the adoptees were identified as having schizophrenia or other types of non-affective psychosis between 1973 and 2006.ALN-VSP02 is Alnylam’s most advanced systemic RNAi system, and employs an initial generation LNP produced by Tekmira Pharmaceuticals Company. ALN-VSP comprises two siRNAs made to focus on two genes crucial for the development and survival of cancers cells: vascular endothelial development element and kinesin spindle protein , also referred to as eglin 5 . Specifically, the company reported new individual pharmacokinetic data that present a clear relationship of individual and pre-clinical animal study findings.